{"id":61363,"date":"2023-09-06T17:17:13","date_gmt":"2023-09-06T17:17:13","guid":{"rendered":"https:\/\/www.inspirenignite.com\/anna-university\/bt3013-biopharmaceuticals-and-biosimilars-syllabus-for-biotech-2021-regulation-professional-elective-iii\/"},"modified":"2023-09-06T17:17:13","modified_gmt":"2023-09-06T17:17:13","slug":"bt3013-biopharmaceuticals-and-biosimilars-syllabus-for-biotech-2021-regulation-professional-elective-iii","status":"publish","type":"post","link":"https:\/\/www.inspirenignite.com\/anna-university\/bt3013-biopharmaceuticals-and-biosimilars-syllabus-for-biotech-2021-regulation-professional-elective-iii\/","title":{"rendered":"BT3013: Biopharmaceuticals and Biosimilars syllabus for BioTech 2021 regulation (Professional Elective-III)"},"content":{"rendered":"

Biopharmaceuticals and Biosimilars detailed syllabus for Biotechnology (BioTech) for 2021 regulation curriculum has been taken from the Anna Universities<\/a> official website and presented for the BioTech students. For course code, course name, number of credits for a course and other scheme related information, do visit full semester subjects post given below. <\/p>\n

For Biotechnology 5th Sem scheme and its subjects, do visit BioTech 5th Sem 2021 regulation scheme<\/a>. For Professional Elective-III scheme and its subjects refer to BioTech Professional Elective-III syllabus scheme<\/a>. The detailed syllabus of biopharmaceuticals and biosimilars is as follows. <\/p>\n

Course Objectives:<\/h4>\n

Download the iStudy App for all syllabus and other updates.<\/a>
\"Get<\/a><\/h4>\n

Unit I<\/h4>\n

INTRODUCTION\t9<\/strong>
\nDrug sources – Discovery and Development phases – Drugs and Cosmetics Act and regulatory aspects – Role of patents in the drug industry – Biopharmaceutical classification system – Drug Target – Drug metabolism – Pharmacokinetics – Pharmacodynamics – Bioavailability -Bioequivalence – Toxicity studies – Pharmacogenomics.\n<\/p>\n

Unit II<\/h4>\n

DOSAGE FORMS\t9<\/strong>
\nClassification of dosage forms – Excipients – Formulation – Tablets, Capsules, Emulsion, Suspension, Lotion, Liniments, Ointments, Cream, Paste, Suppositories, Parenterals – Pressurized dosage forms – Packaging techniques.\n<\/p>\n

Unit III<\/h4>\n

Download the iStudy App for all syllabus and other updates.<\/a>
\"Get<\/a><\/h4>\n

Unit IV<\/h4>\n

BIOSIMILARS\t9<\/strong>
\nBiosimilar medicine – Importance – INN nomenclature system – Key trends in biosimilar product development – Production of biosimilar products – Difficulties with biosimilar drugs – Non clinical and clinical study – Regulation and approval process – Future prospects.\n<\/p>\n

Unit V<\/h4>\n

CASE STUDIES ON BIOPHARMACEUTICALS\t9<\/strong>
\nErythropoietin – Insulin – Somatotropin – Interleukin – Interferon – GMCSF – Blood clotting
\nFactors – Tissue plasminogen activator – Monoclonal antibodies and engineered antibodies.\n<\/p>\n

Course Outcomes:<\/h4>\n

Upon completion of the course, students will be able to<\/p>\n